Breathwork-assisted Treatment for Cannabis Use Disorder: A Proof-of-concept Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Addiction
- Sponsor
- Elias Dakwar
- Enrollment
- 10
- Locations
- 1
- Primary Endpoint
- Safety of the breathing session
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this proof-of-concept study is to evaluate the safety, feasibility and acceptability of a breathwork workshop intervention in individuals with cannabis use disorder.
Detailed Description
This study will test a 1-week breathwork workshop for treatment-seeking adults with a diagnosis of cannabis use disorder. The intervention consists of an enhanced breathing session with evocative music to facilitate experiencing non-ordinary states of consciousness, in addition to brief therapeutic interventions based on Motivational Interviewing and Mindfulness-based Relapse Prevention (MBRP). The primary aim is to test the acceptability, feasibility and safety of enhanced breathwork in a therapeutic framework for cannabis use disorder. In addition, the investigators seek to understand the phenomenology of breathwork that may explain any change related to addictive behaviors, as well as biological changes that occur during the breathwork session through heart rate variability and electroencephalography.
Investigators
Elias Dakwar
Associate Professor of Clinical Psychiatry
New York State Psychiatric Institute
Eligibility Criteria
Inclusion Criteria
- •18-70 years of age
- •Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for active cannabis use disorder.
- •Seeking treatment for their cannabis use
Exclusion Criteria
- •Meets DSM-V criteria for schizophrenia or any psychotic illness or any dissociative disorder (Dissociative identity disorder, Dissociative amnesia, Depersonalization/derealization disorder).
- •Active substance use disorder except for cannabis, nicotine, and caffeine.
- •History of severe withdrawal symptoms (i.e withdrawal seizures).
- •History of dementia, epilepsy or seizures, cardiac arrhythmia, pacemaker/defibrillator, heart failure, asthma, panic disorder and other respiratory illnesses (ie: COPD).
Outcomes
Primary Outcomes
Safety of the breathing session
Time Frame: 24 hours after the breathing session.
Occurrence of adverse effects through a self-reported questionnaire.
Acceptability of the breathwork session
Time Frame: One week after the breathing session.
Acceptability of the breathwork intervention through self-reported questionnaires.
Secondary Outcomes
- Phenomenology of breathwork #2(Obtained 24 hours after the breathing session)
- Heart Rate Variability(Measured during breathing session)
- Change in Cue Reactivity(From baseline to 1 month after the breathing session.)
- Change in Motivation to Quit(From baseline to 1 month after the breathing session.)
- Change in cannabis use(From baseline to 1 month after the breathing session.)
- Phenomenology of breathwork #1(24 hours after the breathing session)
- Electroencephalographic changes(Measured during breathing session)